Healthcare & Life Sciences
Mammoth Biosciences
Brisbane, CA, United Statesmammoth.bio/
aliveseries-c-plus
series-c-plus
Stage
2
Investors
About
Mammoth Biosciences develops ultracompact CRISPR systems for in vivo gene editing therapies, enabling precise genetic modifications in hard-to-reach tissues.
Explore Mammoth Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.